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ABSTRACT
Neural stem cells (NSCs) have recently been identified in mammalian brains, including human.  The long-standing
dogma of “no new neuron” was overturned by the discovery of NSCs in the adult brain.  NSCs are primordial and
uncommitted cells with two characteristic properties; self-renewal and multipotency.  NSCs give rise to various types
of cells in the central nervous system including neurons, astrocytes and oligodendrocytes.  NSCs attract interests of a
large number of researchers in various scientific fields because of their possibility of becoming innovative therapeutic
strategy for neurodegenerative disorders previously considered untreatable.  Recent clinical neuroimaging studies have
suggested that morphological brain changes occur and progress in the course of depression, Alzheimer's disease and
schizophrenia.  The analysis of potentials of psychotropic drugs on NSC function may reveal the pathophysiological
importance of neural network impairment and its repair.  Furthermore, the studies using stem cells such as intra-
venous NSC transplantation can be a useful method to clarify the neural network reconstruction mechanism damaged
in neuropsychiatric disorders.
(Received Jun 11, 2007)
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